Rep. Adam Smith criticizes “Big Ugly Bill” over healthcare cuts

U.S. Rep. Adam Smith Washington%27s 9th District - Official U.S. House headshot
U.S. Rep. Adam Smith Washington%27s 9th District - Official U.S. House headshot
0Comments

Rep. Adam Smith, a longstanding member of the U.S. Congress representing Washington’s 9th district since 1997, recently took to social media to express his concerns regarding a piece of legislation known as the “Big Ugly Bill.” Smith, who replaced Randy Tate in Congress and has served since 1997 following a tenure in the Washington State Senate, shared his perspective on this bill’s potential impacts.

On July 3, 2025, Smith stated that “Under the Big Ugly Bill, 17 million people will lose health coverage due to Medicaid, Affordable Care Act, and Medicare cuts, all to pay for billionaire tax breaks.” He criticized President Trump’s priorities by saying he sees where Trump’s loyalties lie but affirmed his own commitment to the American people by opposing the legislation.

Later that day at 15:35 UTC, Smith elaborated further on social media about the implications of the proposed legislation. He asserted that “The Trump administration is snatching health care away from 17 million Americans” and warned about its effects on food assistance and clean energy sectors. He mentioned discussing these issues with MSNBC.

At approximately half an hour later on July 3rd at 16:07 UTC, Smith emphasized his stance against what he described as “one of the most reckless and cruel legislative efforts I’ve seen in my career.” He highlighted its potential impact on basic healthcare coverage for many families in Washington state.

In addition to serving as a congressman for nearly three decades now, Adam Smith holds degrees from Fordham University and the University of Washington School of Law. Born in Washington D.C., he currently resides in Bellevue at age 57.



Related

Hilary Marston, M.D., M.P.H. Chief Medical Officer (CMO) of the FDA

How many companies in cities across King County received FDA citations in Q3?

There were five companies in cities associated with King County that received FDA citations as a result of five inspections conducted in the county over the third quarter of 2025, according to reports from the U.S. Food and Drug Administration (FDA).

Namandjé N. Bumpus Principal Deputy Commissioner at U.S. Food And Drug Administration (fda)

Cities located in King County saw an FDA inspection of 1 company in October

There was one company in a city associated with King County that received an FDA inspection in October, according to the U.S. Food and Drug Administration.

Mark Raza Principal Deputy Chief Counsel - FDA

How many companies in cities in King County received FDA inspections in Q3?

There were 12 companies in cities associated with King County that received 18 FDA inspections in the third quarter of 2025, according to the U.S. Food and Drug Administration.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from South King News.